These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting Anaerobic Respiration in Kim JH; Spero M; Lebig EG; Lonergan ZR; Trindade IB; Newman DK; Martins-Green M Adv Wound Care (New Rochelle); 2024 Feb; 13(2):53-69. PubMed ID: 37432895 [No Abstract] [Full Text] [Related]
3. Mechanisms of chlorate toxicity and resistance in Pseudomonas aeruginosa. Spero MA; Jones J; Lomenick B; Chou TF; Newman DK Mol Microbiol; 2022 Oct; 118(4):321-335. PubMed ID: 36271736 [TBL] [Abstract][Full Text] [Related]
4. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Field TR; White A; Elborn JS; Tunney MM Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934 [TBL] [Abstract][Full Text] [Related]
5. Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions. McCaughey G; Gilpin DF; Schneiders T; Hoffman LR; McKevitt M; Elborn JS; Tunney MM Antimicrob Agents Chemother; 2013 Nov; 57(11):5406-14. PubMed ID: 23959314 [TBL] [Abstract][Full Text] [Related]
6. Tobramycin Adaptation Enhances Policing of Social Cheaters in Pseudomonas aeruginosa. Abisado RG; Kimbrough JH; McKee BM; Craddock VD; Smalley NE; Dandekar AA; Chandler JR Appl Environ Microbiol; 2021 May; 87(12):e0002921. PubMed ID: 33837019 [TBL] [Abstract][Full Text] [Related]
7. Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms. Borriello G; Richards L; Ehrlich GD; Stewart PS Antimicrob Agents Chemother; 2006 Jan; 50(1):382-4. PubMed ID: 16377718 [TBL] [Abstract][Full Text] [Related]
9. Parallel Evolution of Tobramycin Resistance across Species and Environments. Scribner MR; Santos-Lopez A; Marshall CW; Deitrick C; Cooper VS mBio; 2020 May; 11(3):. PubMed ID: 32457248 [TBL] [Abstract][Full Text] [Related]
10. Motility-Independent Formation of Antibiotic-Tolerant Pseudomonas aeruginosa Aggregates. Demirdjian S; Sanchez H; Hopkins D; Berwin B Appl Environ Microbiol; 2019 Jul; 85(14):. PubMed ID: 31076438 [No Abstract] [Full Text] [Related]
11. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Walters MC; Roe F; Bugnicourt A; Franklin MJ; Stewart PS Antimicrob Agents Chemother; 2003 Jan; 47(1):317-23. PubMed ID: 12499208 [TBL] [Abstract][Full Text] [Related]
12. Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms. Stewart PS; Franklin MJ; Williamson KS; Folsom JP; Boegli L; James GA Antimicrob Agents Chemother; 2015 Jul; 59(7):3838-47. PubMed ID: 25870065 [TBL] [Abstract][Full Text] [Related]
13. Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions. Boulanger S; Mitchell G; Bouarab K; Marsault É; Cantin A; Frost EH; Déziel E; Malouin F Antimicrob Agents Chemother; 2015 Dec; 59(12):7458-64. PubMed ID: 26392496 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of Aminoglycoside Lethality by C Hall CW; Farkas E; Zhang L; Mah TF Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383655 [TBL] [Abstract][Full Text] [Related]
15. Computationally designed pyocyanin demethylase acts synergistically with tobramycin to kill recalcitrant VanDrisse CM; Lipsh-Sokolik R; Khersonsky O; Fleishman SJ; Newman DK Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723058 [No Abstract] [Full Text] [Related]
16. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms. Habash MB; Goodyear MC; Park AJ; Surette MD; Vis EC; Harris RJ; Khursigara CM Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848007 [TBL] [Abstract][Full Text] [Related]
17. Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections. Ham SY; Kim HS; Jo MJ; Lee JH; Byun Y; Ko GJ; Park HD Microbiol Spectr; 2021 Oct; 9(2):e0019221. PubMed ID: 34704784 [TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077 [TBL] [Abstract][Full Text] [Related]
19. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL mBio; 2017 Jul; 8(4):. PubMed ID: 28743808 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G; McKevitt M; Elborn JS; Tunney MM J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]